Maria Rosaria Valerio

3PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 26, 2026
Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial.

Giampaolo Bianchini, Luca Malorni, Roberta Caputo

|Apr 28, 2023
Letter to the Editor: statistics and clinical perception of patients' reported outcomes for palbociclib and abemaciclib: a sliding doors story.

Vittorio Gebbia, Maria Rosaria Valerio, Federica Martorana

|Aug 28, 2021
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9).

Rosalba Torrisi, Raffaella Palumbo, Rita De Sanctis

Pageof 1

Frequent Collaborators

2 joint publications

Marina Elena Cazzaniga

1 joint publications

Rosalba Torrisi

1 joint publications

Raffaella Palumbo

1 joint publications

Rita De Sanctis